Lori C Sakoda
Overview
Explore the profile of Lori C Sakoda including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
161
Citations
3640
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Henderson L, Kim R, Tanner N, Tsai E, Begnaud A, Dako F, et al.
Am J Respir Crit Care Med
. 2025 Feb;
211(3):436-451.
PMID: 39928329
Lung cancer screening with low-dose computed tomography (LDCT) may uncover incidental findings (IFs) unrelated to lung cancer. There may be potential benefits from identifying clinically significant IFs that warrant intervention...
2.
Middha P, Kachuri L, Nierenberg J, Graff R, Cavazos T, Hoffmann T, et al.
HGG Adv
. 2025 Feb;
6(2):100413.
PMID: 39910817
With advances in cancer screening and treatment, there is a growing population of cancer survivors who may develop subsequent primary cancers. While hereditary cancer syndromes account for only a portion...
3.
Tupper H, Sarovar V, Banks K, Schmittdiel J, Hsu D, Ashiku S, et al.
J Thorac Cardiovasc Surg
. 2024 Dec;
PMID: 39674315
Background: Most patient variables that impact cancer case complexity and outcomes are not modifiable preoperatively; however, the time from diagnosis to surgical resection is fluid. This retrospective study sought to...
4.
Lee Jr H, Boscardin J, Walter L, Smith A, Cohen H, Giri S, et al.
Oncologist
. 2024 Dec;
PMID: 39657913
Introduction: Among older adults with cancer receiving chemotherapy, frailty indices predict OS and toxicity. Given the increased use of immunotherapy and targeted therapy for advanced non-small cell lung cancer (aNSCLC),...
5.
Middha P, Kachuri L, Nierenberg J, Graff R, Cavazos T, Hoffmann T, et al.
medRxiv
. 2024 Nov;
PMID: 39574869
With advances in cancer screening and treatment, there is a growing population of cancer survivors who may develop subsequent primary cancers. While hereditary cancer syndromes account for only a portion...
6.
Gomez S, DeRouen M, Chen Jr M, Wakelee H, Velotta J, Sakoda L, et al.
J Natl Cancer Inst
. 2024 Nov;
PMID: 39565906
Lung cancer is a leading cause of cancer mortality for most ethnic groups of Asian American females, including Chinese, Korean, Japanese, and Vietnamese Americans, a striking pattern given the exceedingly...
7.
Thomas C, Lin Y, Kim M, Kawaguchi E, Qu C, Um C, et al.
Epidemiology
. 2024 Sep;
36(1):126-138.
PMID: 39316822
Background: Colorectal cancer (CRC) is a common, fatal cancer. Identifying subgroups who may benefit more from intervention is of critical public health importance. Previous studies have assessed multiplicative interaction between...
8.
Backhus L, Chang C, Sakoda L, Chambers S, Henderson L, Henschke C, et al.
Cancer
. 2024 Sep;
130(23):3985-3995.
PMID: 39302237
Lung cancer in women is a modern epidemic and represents a global health crisis. Cigarette smoking remains the most important risk factor for lung cancer in all patients and, among...
9.
Singhal S, Walter L, Smith A, Boscardin W, Shi Y, Cohen H, et al.
J Geriatr Oncol
. 2024 Sep;
15(8):102068.
PMID: 39288505
Introduction: Among older adults without cancer, living alone is associated with poor health outcomes. However, among older adults with non-small cell lung cancer (NSCLC) who live alone, data on function,...
10.
Chua Jr A, Delmerico J, Sheng H, Huang X, Liang E, Yan L, et al.
JCO Oncol Pract
. 2024 Aug;
21(3):408-417.
PMID: 39173090
Purpose: Minoritized racial/ethnic groups are historically under-represented in cancer clinical trials, which may be exacerbated in recent trials on immune checkpoint inhibitors (ICIs). We examined the representation and reporting of...